127 related articles for article (PubMed ID: 10681768)
21. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.
Bourhis J; Rosine D
Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247
[TBL] [Abstract][Full Text] [Related]
22. Prevention of radioinduced cystitis by orgotein: a randomized study.
Sanchiz F; Millá A; Artola N; Julià JC; Moya LM; Pedro A; Vila A
Anticancer Res; 1996; 16(4A):2025-8. PubMed ID: 8712737
[TBL] [Abstract][Full Text] [Related]
23. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
24. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Abdous B; Vigneault E; Vass S; Del Vecchio P; Roy J
J Clin Oncol; 2005 Aug; 23(24):5805-13. PubMed ID: 16027437
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
[TBL] [Abstract][Full Text] [Related]
27. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
28. [Prevention and treatment of skin injuries with cygerol ointment in radiation therapy].
Noskov AG
Med Radiol (Mosk); 1967 Mar; 12(3):55-8. PubMed ID: 5620462
[No Abstract] [Full Text] [Related]
29. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
de Castro G; Federico MH
Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
[TBL] [Abstract][Full Text] [Related]
30. [Influence of Fleming's lysozyme on leukopenia due to radiotherapy. Case contribution].
Ferri GG; Pozza F; Calzavara F
Quad Radiol; 1965; 30(4):759-66. PubMed ID: 5860889
[No Abstract] [Full Text] [Related]
31. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial.
Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1088-97. PubMed ID: 15519779
[TBL] [Abstract][Full Text] [Related]
32. Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
Bardet E; Martin L; Calais G; Tuchais C; Bourhis J; Rhein B; Feham N; Alphonsi M
Semin Oncol; 2002 Dec; 29(6 Suppl 19):57-60. PubMed ID: 12577246
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic damage induced by radiotherapy. Evaluation of protection by amifostine and analysis of chromosome aberrations persistence.
Xunclà M; Barquinero JF; Caballín MR; Craven-Bartle J; Ribas M; de Vega JM; Barrios L
Int J Radiat Biol; 2008 Mar; 84(3):243-51. PubMed ID: 18300025
[TBL] [Abstract][Full Text] [Related]
34. A randomized phase II trial of amifostine for head and neck irradiation in lymphoma.
Ng AK; Hickey G; Li S; Neuberg D; Mauch PM
Semin Oncol; 2004 Dec; 31(6 Suppl 18):20-4. PubMed ID: 15726518
[TBL] [Abstract][Full Text] [Related]
35. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
[TBL] [Abstract][Full Text] [Related]
36. [The use of sucralfate in radiation oncology].
Belka C; Hoffmann W; Paulsen F; Barnberg M
Strahlenther Onkol; 1997 May; 173(5):247-52. PubMed ID: 9198905
[TBL] [Abstract][Full Text] [Related]
37. [Changes of superoxide dismutase (SOD) and metallothionien (MT) before, during, and after radiotherapy for nasopharyngeal carcinoma and their significance].
Su Y; Xia YF; Yang HL; He JH; Wu QL; Zheng Q; Hou JH
Ai Zheng; 2003 Jun; 22(6):629-33. PubMed ID: 12948415
[TBL] [Abstract][Full Text] [Related]
38. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study.
Lin LC; Que J; Lin LK; Lin FC
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):745-50. PubMed ID: 16751063
[TBL] [Abstract][Full Text] [Related]
39. Research progress in the radioprotective effect of superoxide dismutase.
Huang XJ; Song CX; Zhong CQ; Wang FS
Drug Discov Ther; 2012 Aug; 6(4):169-77. PubMed ID: 23006987
[TBL] [Abstract][Full Text] [Related]
40. [Action of liposomal superoxide dismutase on measurable radiation-induced fibrosis].
Housset M; Baillet F; Michelson AM; Puget K
Ann Med Interne (Paris); 1989; 140(5):365-7. PubMed ID: 2596781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
